CN112075639A - Composite polypeptide powder capable of enhancing immunity and preparation method thereof - Google Patents
Composite polypeptide powder capable of enhancing immunity and preparation method thereof Download PDFInfo
- Publication number
- CN112075639A CN112075639A CN201910516555.4A CN201910516555A CN112075639A CN 112075639 A CN112075639 A CN 112075639A CN 201910516555 A CN201910516555 A CN 201910516555A CN 112075639 A CN112075639 A CN 112075639A
- Authority
- CN
- China
- Prior art keywords
- parts
- polypeptide powder
- enhancing immunity
- powder capable
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 109
- 239000000843 powder Substances 0.000 title claims abstract description 72
- 230000036039 immunity Effects 0.000 title claims abstract description 51
- 229920001184 polypeptide Polymers 0.000 title claims abstract description 51
- 102000004196 processed proteins & peptides Human genes 0.000 title claims abstract description 51
- 230000002708 enhancing effect Effects 0.000 title claims abstract description 48
- 239000002131 composite material Substances 0.000 title claims abstract description 39
- 238000002360 preparation method Methods 0.000 title abstract description 16
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 63
- 244000068988 Glycine max Species 0.000 claims abstract description 28
- 240000005662 Aronia melanocarpa Species 0.000 claims abstract description 27
- 235000007425 Aronia melanocarpa Nutrition 0.000 claims abstract description 27
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 27
- 240000008042 Zea mays Species 0.000 claims abstract description 26
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 26
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 26
- 235000005822 corn Nutrition 0.000 claims abstract description 26
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims abstract description 21
- 229920001202 Inulin Polymers 0.000 claims abstract description 21
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims abstract description 21
- 239000004376 Sucralose Substances 0.000 claims abstract description 21
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims abstract description 21
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 21
- 229940029339 inulin Drugs 0.000 claims abstract description 21
- 235000011090 malic acid Nutrition 0.000 claims abstract description 21
- 239000001630 malic acid Substances 0.000 claims abstract description 21
- 239000001509 sodium citrate Substances 0.000 claims abstract description 21
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims abstract description 21
- 229940013618 stevioside Drugs 0.000 claims abstract description 21
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000019202 steviosides Nutrition 0.000 claims abstract description 21
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims abstract description 21
- 235000019408 sucralose Nutrition 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 5
- 238000001035 drying Methods 0.000 claims description 33
- 238000003756 stirring Methods 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 26
- 235000015165 citric acid Nutrition 0.000 claims description 20
- 239000002245 particle Substances 0.000 claims description 16
- 150000001875 compounds Chemical class 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 238000005469 granulation Methods 0.000 claims description 8
- 230000003179 granulation Effects 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000004806 packaging method and process Methods 0.000 claims description 8
- 238000007873 sieving Methods 0.000 claims description 8
- 235000011083 sodium citrates Nutrition 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 230000000694 effects Effects 0.000 abstract description 8
- 238000009776 industrial production Methods 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 3
- 238000012360 testing method Methods 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 2
- 235000010208 anthocyanin Nutrition 0.000 description 2
- 229930002877 anthocyanin Natural products 0.000 description 2
- 239000004410 anthocyanin Substances 0.000 description 2
- 150000004636 anthocyanins Chemical class 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241001633583 Adenophora Species 0.000 description 1
- 241001444063 Aronia Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 241000693079 Maloideae Species 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019710 soybean protein Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
- A23P10/47—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added using additives, e.g. emulsifiers, wetting agents or dust-binding agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses composite polypeptide powder capable of enhancing immunity and a preparation method thereof, wherein the composite polypeptide powder capable of enhancing immunity comprises the following raw materials in parts by weight: 2-4 parts of aronia melanocarpa concentrated powder, 60-90 parts of inulin, 0.5-3 parts of corn peptide, 10-20 parts of soybean peptide, 0.3-0.7 part of stevioside, 0.05-0.1 part of sucralose, 3-5 parts of citric acid, 1-2 parts of malic acid and 0.1-0.2 part of sodium citrate. The composite polypeptide powder capable of enhancing immunity has the effects of enhancing immunity and resisting fatigue, and is widely suitable for various crowds; the preparation method of the composite polypeptide powder capable of enhancing immunity, disclosed by the invention, is simple in process and suitable for large-scale industrial production, and the prepared composite polypeptide powder is good in health-care effect and has a good application prospect.
Description
Technical Field
The invention relates to the technical field of health care medicines, in particular to composite polypeptide powder capable of enhancing immunity and a preparation method thereof.
Background
In recent years, scientific research shows that the small molecular peptide as a functional active fragment of protein not only has higher nutritive value than protein, can provide nutrient substances required by the growth and development of human body, but also has unique physiological activity which many proteins do not have. The peptide is in the form of life existence, and the renewal, metabolism, growth and repair of cells can not be separated from the peptide, so that the peptide is applied to various health foods, and can rapidly enhance, activate and repair low immune function, degraded immune function and immune dysfunction.
The soybean peptide is also called soybean polypeptide, is an enzymolysis product of soybean protein, and is usually a peptide mixture consisting of 3-6 amino acids, and the molecular weight of the soybean peptide is mainly concentrated below 1000. The soybean peptide contains arginine and glutamic acid. Glutamate can produce immune cells, and can repel viruses. Arginine can increase the size and health degree of thymus, an important immune organ of a human body, and enhance the immunity. The soybean peptide is absorbed by the intestinal tract much faster than protein and amino acid, and has important functions of obtaining sufficient amino acid source for human body, rapidly repairing damaged muscle and eliminating fatigue.
The corn peptide is a small molecular polypeptide substance obtained by directional enzyme digestion and a specific small peptide separation technology of protein extracted from corn. The content of glutamine in the composition of the corn peptide amino acid is very high, and the glutamine is closely related to tissue growth and repair, and has important values in improving the immunity of the organism, maintaining the normal structure and function of intestinal mucosa and improving the capability of the organism to adapt to external harmful stimulation.
The Aronia melanocarpa fruit, commonly known as Aronia melanocarpa, belongs to Aronia adenophora of Maloideae of Rosaceae. Aronia melanocarpa berries are one of the most abundant plants of anthocyanin and have extremely strong free radical scavenging activity of antioxidants. The Aronia melanocarpa anthocyanin can activate immune system, prevent serum immunoglobulin from being invaded by free radicals, activate macrophage and enhance human immunity.
In the prior art, no special medicine is available for organically combining the beneficial components to prepare the tabletting candy which has comprehensive nutritional value and outstanding efficacy and is convenient to eat.
Disclosure of Invention
The invention aims to overcome the defects, provides the composite polypeptide powder capable of enhancing the immunity, has the effects of enhancing the immunity and resisting fatigue, and is widely suitable for various crowds; in addition, the invention also provides a preparation method of the composite polypeptide powder capable of enhancing immunity, the process is simple, the composite polypeptide powder is suitable for large-scale industrial production, and the prepared composite polypeptide powder has a good health-care effect and a good application prospect.
In order to achieve the purpose, the invention provides composite polypeptide powder capable of enhancing immunity in a first aspect, which comprises the following raw materials in parts by weight: 2-4 parts of aronia melanocarpa concentrated powder, 60-90 parts of inulin, 0.5-3 parts of corn peptide, 10-20 parts of soybean peptide, 0.3-0.7 part of stevioside, 0.05-0.1 part of sucralose, 3-5 parts of citric acid, 1-2 parts of malic acid and 0.1-0.2 part of sodium citrate.
Furthermore, the preferable raw materials for preparing the composite polypeptide powder capable of enhancing immunity of the invention comprise the following components in parts by weight: 2.5 parts of aronia melanocarpa concentrated powder, 76 parts of inulin, 1 part of corn peptide, 12 parts of soybean peptide, 0.4 part of stevioside, 0.08 part of sucralose, 3.5 parts of citric acid, 1.8 parts of malic acid and 0.18 part of sodium citrate.
Furthermore, the preferable raw materials for preparing the composite polypeptide powder capable of enhancing immunity of the invention comprise the following components in parts by weight: the material comprises the following raw materials in percentage by mass: 3.5 parts of aronia melanocarpa concentrated powder, 60-90 parts of inulin, 2 parts of corn peptide, 18 parts of soybean peptide, 0.6 part of stevioside, 0.06 part of sucralose, 4.5 parts of citric acid, 1.2 parts of malic acid and 0.12 part of sodium citrate.
The invention provides a preparation method of composite polypeptide powder capable of enhancing immunity, which comprises the following steps:
s1, sequentially putting the aronia melanocarpa concentrated powder, inulin, corn peptide, soybean peptide, stevioside, sucralose, citric acid, malic acid and sodium citrate into a stirring pot, and stirring and mixing for 20-30 minutes;
s2, adding 80% ethanol by volume fraction into the stirring pot in the step S1, continuously stirring for 10-20 minutes, and then sending the mixture to a granulator for granulation;
s3, conveying the particles manufactured by the granulator in the step S2 into a drying oven for drying, wherein the drying temperature is 50-65 ℃, and the drying is stopped when the water content is tested to be 3-5 parts;
s4, sieving the dried particles obtained in the step S4 by using a 80-mesh sieve, and packaging to obtain the compound polypeptide powder capable of enhancing the immunity.
Compared with the prior art, the invention has the beneficial effects that:
1. the composite polypeptide powder capable of enhancing immunity has the effects of enhancing immunity and resisting fatigue, and is widely suitable for various crowds; the soybean peptide, the corn peptide and the aronia melanocarpa concentrated powder are main raw materials in the composite polypeptide powder capable of enhancing the immunity, and the immunity enhancing and anti-fatigue effects of the composite polypeptide powder are optimal through the synergistic effect among the soybean peptide, the corn peptide and the aronia melanocarpa concentrated powder and the scientific compatibility among the raw materials.
2. The preparation method of the composite polypeptide powder capable of enhancing immunity, disclosed by the invention, is simple in process and suitable for large-scale industrial production, and the prepared composite polypeptide powder is good in health-care effect and has a good application prospect.
3. According to the preparation method of the composite polypeptide powder capable of enhancing immunity, ethanol with the volume fraction of 80% is used as a solvent, so that the drying time in the step S3 can be greatly reduced, and the production cost of the composite polypeptide powder is reduced.
Drawings
FIG. 1 is a schematic flow chart of a method for preparing a composite polypeptide powder capable of enhancing immunity according to the present invention.
Detailed Description
In order to make the technical means, the characteristics, the purposes and the functions of the invention easy to understand, the invention is further described with reference to the specific drawings.
Example 1
The composite polypeptide powder capable of enhancing immunity comprises the following raw materials in parts by weight: 2g of aronia melanocarpa concentrated powder, 65g of inulin, 0.6g of corn peptide, 12g of soybean peptide, 0.3g of stevioside, 0.05g of sucralose, 3.1g of citric acid, 1g of malic acid and 0.1g of sodium citrate.
Referring to fig. 1, the preparation method of the composite polypeptide powder capable of enhancing immunity in this embodiment includes the following steps:
s1, sequentially putting the aronia melanocarpa concentrated powder, inulin, corn peptide, soybean peptide, stevioside, sucralose, citric acid, malic acid and sodium citrate into a stirring pot, and stirring and mixing for 25 minutes;
s2, adding 80% ethanol by volume fraction into the stirring pot in the step S1, continuously stirring for 150 minutes, and then sending the mixture to a granulator for granulation;
s3, conveying the particles manufactured by the granulator in the step S2 into a drying oven for drying, wherein the drying temperature is 60 ℃, and the drying is stopped when the water content is 3g in the test;
s4, sieving the dried particles obtained in the step S4 by using a 80-mesh sieve, and packaging to obtain the compound polypeptide powder capable of enhancing the immunity.
Example 2
The composite polypeptide powder capable of enhancing immunity comprises the following raw materials in parts by weight: 4g of aronia melanocarpa concentrated powder, 75g of inulin, 2.8g of corn peptide, 20g of soybean peptide, 0.5g of stevioside, 0.1g of sucralose, 4g of citric acid, 2g of malic acid and 0.2g of sodium citrate.
Referring to fig. 1, the preparation method of the composite polypeptide powder capable of enhancing immunity in this embodiment includes the following steps:
s1, sequentially putting the aronia melanocarpa concentrated powder, inulin, corn peptide, soybean peptide, stevioside, sucralose, citric acid, malic acid and sodium citrate into a stirring pot, and stirring and mixing for 30 minutes;
s2, adding 80% ethanol by volume fraction into the stirring pot in the step S1, continuously stirring for 200 minutes, and then sending the mixture to a granulator for granulation;
s3, conveying the particles manufactured by the granulator in the step S2 into a drying oven for drying, wherein the drying temperature is 60 ℃, and the drying is stopped when the water content is 3g in the test;
s4, sieving the dried particles obtained in the step S4 by using a 80-mesh sieve, and packaging to obtain the compound polypeptide powder capable of enhancing the immunity.
Example 3
The composite polypeptide powder capable of enhancing immunity comprises the following raw materials in parts by weight: 2.5g of aronia melanocarpa concentrated powder, 76g of inulin, 1g of corn peptide, 12g of soybean peptide, 0.4g of stevioside, 0.08g of sucralose, 3.5g of citric acid, 1.8g of malic acid and 0.18g of sodium citrate.
Referring to fig. 1, the preparation method of the composite polypeptide powder capable of enhancing immunity in this embodiment includes the following steps:
s1, sequentially putting the aronia melanocarpa concentrated powder, inulin, corn peptide, soybean peptide, stevioside, sucralose, citric acid, malic acid and sodium citrate into a stirring pot, and stirring and mixing for 28 minutes;
s2, adding 80% ethanol by volume fraction into the stirring pot in the step S1, continuously stirring for 20 minutes, and then sending the mixture to a granulator for granulation;
s3, conveying the particles manufactured by the granulator in the step S2 into a drying oven for drying, wherein the drying temperature is 60 ℃, and the drying is stopped when the water content is 3g in the test;
s4, sieving the dried particles obtained in the step S4 by using a 80-mesh sieve, and packaging to obtain the compound polypeptide powder capable of enhancing the immunity.
Example 4
The composite polypeptide powder capable of enhancing immunity comprises the following raw materials in parts by weight: 3.5g of aronia melanocarpa concentrated powder, 65g of inulin, 2g of corn peptide, 18g of soybean peptide, 0.6g of stevioside, 0.06g of sucralose, 4.5g of citric acid, 1.2g of malic acid and 0.12g of sodium citrate.
Referring to fig. 1, the preparation method of the composite polypeptide powder capable of enhancing immunity in this embodiment includes the following steps:
s1, sequentially putting the aronia melanocarpa concentrated powder, inulin, corn peptide, soybean peptide, stevioside, sucralose, citric acid, malic acid and sodium citrate into a stirring pot, and stirring and mixing for 20-30 minutes;
s2, adding 80% ethanol by volume fraction into the stirring pot in the step S1, continuously stirring for 10-20 minutes, and then sending the mixture to a granulator for granulation;
s3, conveying the particles manufactured by the granulator in the step S2 into a drying oven for drying, wherein the drying temperature is 50-65 ℃, and the drying is stopped when the water content is 3-5 g in the test;
s4, sieving the dried particles obtained in the step S4 by using a 80-mesh sieve, and packaging to obtain the compound polypeptide powder capable of enhancing the immunity.
Example 5
The composite polypeptide powder capable of enhancing immunity comprises the following raw materials in parts by weight: 3.5g of aronia melanocarpa concentrated powder, 90g of inulin, 2g of corn peptide, 18g of soybean peptide, 0.6g of stevioside, 0.06g of sucralose, 4.5g of citric acid, 1.2g of malic acid and 0.12g of sodium citrate.
Referring to fig. 1, the preparation method of the composite polypeptide powder capable of enhancing immunity in this embodiment includes the following steps:
s1, sequentially putting the aronia melanocarpa concentrated powder, inulin, corn peptide, soybean peptide, stevioside, sucralose, citric acid, malic acid and sodium citrate into a stirring pot, and stirring and mixing for 20-30 minutes;
s2, adding 80% ethanol by volume fraction into the stirring pot in the step S1, continuously stirring for 10-20 minutes, and then sending the mixture to a granulator for granulation;
s3, conveying the particles manufactured by the granulator in the step S2 into a drying oven for drying, wherein the drying temperature is 50-65 ℃, and the drying is stopped when the water content is 3-5 g in the test;
s4, sieving the dried particles obtained in the step S4 by using a 80-mesh sieve, and packaging to obtain the compound polypeptide powder capable of enhancing the immunity.
Example 6
The composite polypeptide powder capable of enhancing immunity comprises the following raw materials in parts by weight: 3.5g of aronia melanocarpa concentrated powder, 80g of inulin, 2g of corn peptide, 18g of soybean peptide, 0.6g of stevioside, 0.06g of sucralose, 4.5g of citric acid, 1.2g of malic acid and 0.12g of sodium citrate.
Referring to fig. 1, the preparation method of the composite polypeptide powder capable of enhancing immunity in this embodiment includes the following steps:
s1, sequentially putting the aronia melanocarpa concentrated powder, inulin, corn peptide, soybean peptide, stevioside, sucralose, citric acid, malic acid and sodium citrate into a stirring pot, and stirring and mixing for 20-30 minutes;
s2, adding 80% ethanol by volume fraction into the stirring pot in the step S1, continuously stirring for 10-20 minutes, and then sending the mixture to a granulator for granulation;
s3, conveying the particles manufactured by the granulator in the step S2 into a drying oven for drying, wherein the drying temperature is 50-65 ℃, and the drying is stopped when the water content is 3-5 g in the test;
s4, sieving the dried particles obtained in the step S4 by using a 80-mesh sieve, and packaging to obtain the compound polypeptide powder capable of enhancing the immunity.
The composite polypeptide powder capable of enhancing immunity, which is prepared by the invention, has the effects of enhancing immunity and resisting fatigue, is widely suitable for various crowds, is simple in preparation method, is suitable for large-scale industrial production, and has a good application prospect.
Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.
Claims (4)
1. The composite polypeptide powder capable of enhancing immunity is characterized by comprising the following raw materials in parts by weight: 2-4 parts of aronia melanocarpa concentrated powder, 60-90 parts of inulin, 0.5-3 parts of corn peptide, 10-20 parts of soybean peptide, 0.3-0.7 part of stevioside, 0.05-0.1 part of sucralose, 3-5 parts of citric acid, 1-2 parts of malic acid and 0.1-0.2 part of sodium citrate.
2. The compound polypeptide powder capable of enhancing immunity as claimed in claim 1, which comprises the following raw materials in parts by weight: 2.5 parts of aronia melanocarpa concentrated powder, 76 parts of inulin, 1 part of corn peptide, 12 parts of soybean peptide, 0.4 part of stevioside, 0.08 part of sucralose, 3.5 parts of citric acid, 1.8 parts of malic acid and 0.18 part of sodium citrate.
3. The compound polypeptide powder capable of enhancing immunity as claimed in claim 1, which comprises the following raw materials in parts by weight: 3.5 parts of aronia melanocarpa concentrated powder, 60-90 parts of inulin, 2 parts of corn peptide, 18 parts of soybean peptide, 0.6 part of stevioside, 0.06 part of sucralose, 4.5 parts of citric acid, 1.2 parts of malic acid and 0.12 part of sodium citrate.
4. The method for preparing the composite polypeptide powder capable of enhancing immunity according to any one of claims 1 to 3, comprising the following steps:
s1, sequentially putting the aronia melanocarpa concentrated powder, inulin, corn peptide, soybean peptide, stevioside, sucralose, citric acid, malic acid and sodium citrate into a stirring pot, and stirring and mixing for 20-30 minutes;
s2, adding 80% ethanol by volume fraction into the stirring pot in the step S1, continuously stirring for 10-20 minutes, and then sending the mixture to a granulator for granulation;
s3, conveying the particles manufactured by the granulator in the step S2 into a drying oven for drying, wherein the drying temperature is 50-65 ℃, and the drying is stopped when the water content is tested to be 3-5 parts;
s4, sieving the dried particles obtained in the step S4 by using a 80-mesh sieve, and packaging to obtain the compound polypeptide powder capable of enhancing the immunity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910516555.4A CN112075639A (en) | 2019-06-14 | 2019-06-14 | Composite polypeptide powder capable of enhancing immunity and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910516555.4A CN112075639A (en) | 2019-06-14 | 2019-06-14 | Composite polypeptide powder capable of enhancing immunity and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112075639A true CN112075639A (en) | 2020-12-15 |
Family
ID=73734023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910516555.4A Pending CN112075639A (en) | 2019-06-14 | 2019-06-14 | Composite polypeptide powder capable of enhancing immunity and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112075639A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114081186A (en) * | 2022-01-20 | 2022-02-25 | 南京浩明乳业有限责任公司 | Oligomeric polypeptide powder and processing technology thereof |
| CN116114871A (en) * | 2023-01-31 | 2023-05-16 | 山东健奕宏生物制药有限公司 | Chinese health-preserving composition for enhancing immunity and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107242422A (en) * | 2017-04-11 | 2017-10-13 | 广东时代食品与生命健康研究有限公司 | It is a kind of to improve immunity of organisms and recover plant molecular peptide solid beverage of physical efficiency and preparation method thereof |
| CN108077522A (en) * | 2017-12-28 | 2018-05-29 | 天津科技大学 | A kind of compound pressed candy of Black Box Tracing and preparation method thereof |
| CN109730307A (en) * | 2019-01-10 | 2019-05-10 | 蕴彤本草(北京)生物科技有限公司 | The composite nutrient and the preparation method and application thereof for preventing and treating hypertension, hyperlipemia disease |
| CN109845878A (en) * | 2018-11-08 | 2019-06-07 | 武汉森澜生物科技有限公司 | A kind of compound protein peptide of strengthen immunity and its application |
-
2019
- 2019-06-14 CN CN201910516555.4A patent/CN112075639A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107242422A (en) * | 2017-04-11 | 2017-10-13 | 广东时代食品与生命健康研究有限公司 | It is a kind of to improve immunity of organisms and recover plant molecular peptide solid beverage of physical efficiency and preparation method thereof |
| CN108077522A (en) * | 2017-12-28 | 2018-05-29 | 天津科技大学 | A kind of compound pressed candy of Black Box Tracing and preparation method thereof |
| CN109845878A (en) * | 2018-11-08 | 2019-06-07 | 武汉森澜生物科技有限公司 | A kind of compound protein peptide of strengthen immunity and its application |
| CN109730307A (en) * | 2019-01-10 | 2019-05-10 | 蕴彤本草(北京)生物科技有限公司 | The composite nutrient and the preparation method and application thereof for preventing and treating hypertension, hyperlipemia disease |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114081186A (en) * | 2022-01-20 | 2022-02-25 | 南京浩明乳业有限责任公司 | Oligomeric polypeptide powder and processing technology thereof |
| CN116114871A (en) * | 2023-01-31 | 2023-05-16 | 山东健奕宏生物制药有限公司 | Chinese health-preserving composition for enhancing immunity and preparation method and application thereof |
| CN116114871B (en) * | 2023-01-31 | 2023-09-22 | 浙江吉美食品科技有限公司 | Chinese health-preserving composition for enhancing immunity and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102578450A (en) | Healthcare food capable of strengthening immunity and preparing method thereof | |
| US20100015283A1 (en) | Method of Preparing Powder Kimchi and Kimchi Composition Using the Same | |
| CN1911062A (en) | Vegetable source natural selenium-rich peptide, prepn. method and use thereof | |
| CN105455001A (en) | Eel bone, barbary wolfberry and water spinach juice noodles and preparation method thereof | |
| KR101793123B1 (en) | preparing method of fermented soybean enhancing physiological active substance and the physiological active substance thereby | |
| CN110195090A (en) | The preparation method and gained sea cucumber intestine ovum polypeptide powder of sea cucumber intestine ovum polypeptide powder | |
| CN112075639A (en) | Composite polypeptide powder capable of enhancing immunity and preparation method thereof | |
| CN104738638A (en) | Composition with anti-fatigue effect and application thereof | |
| CN110628859A (en) | Glycosylated oyster peptide and preparation method thereof | |
| CN109757733A (en) | A kind of oral polypeptide powder and its preparation method and application | |
| CN109402204A (en) | A kind of preparation method of chlorella immune-active peptides | |
| CN112890064A (en) | Composite collagen peptide solid beverage and preparation method thereof | |
| KR20200028746A (en) | Gruel comprising Tenebrio molitor and manufacturing method thereof | |
| CN106174475B (en) | A kind of selenoprotein holoside nutrient composite powder and preparation method thereof | |
| CN105859839B (en) | A kind of biologically active peptide and its preparation method and application promoting piglet growth | |
| CN102078340A (en) | Protein nutritious product as well as preparation method and application thereof | |
| CN113875881A (en) | Hermetia illucens feed protein and preparation method thereof | |
| KR101100337B1 (en) | Manufacturing method of granular tea using Phellinus linteus | |
| JPH07284375A (en) | Immune-enhanced food compound mainly of isaria-type 'tochu-kaso' | |
| CN101396378B (en) | Nano gene peptides products and preparation method and use thereof | |
| CN106689756B (en) | Feed additive for improving appetite and digestion function of weaned piglets and preparation method and application thereof | |
| CN1552892A (en) | Physiological active buck peptide by compound proteinase catalysis and use of products thereby | |
| CN105341238A (en) | Chlorella polypeptide tea and manufacturing method thereof | |
| CN105851860A (en) | Honeysuckle intelligence-improving and restlessness-relieving nut flour and preparation method thereof | |
| CN108977484A (en) | The extracting method of oat polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201215 |